.webp)
Search results
Medable’s Privacy Statement applies to your use of the Medable.com websites (the “Sites”) as well as certain Medable Services (the “Services”).
Medable’s Privacy Statement applies to your use of the Medable.com websites (the “Sites”) as well as certain Medable Services (the “Services”).
Learn how sponsors and CROs can improve their clinical trial conduct by developing new strategies that create sustainable, repeatable, and effective clinical conduct.
Watch the on-demand panel discussion between Medable, Syneos, Illingworth and Veeva, moderated by Gilead, as they discuss how the next generation of clinical development is now.
Musaddiq Khan explains how the landscape of clinical trials is undergoing a significant transformation as digital measures and digital health technologies (DHTs) continue to evolve and prove their worth.
Medable's GM of eConsent, Andrew Mackinnon, Customer Success Lead at Innovative Supply Solutions, Martha LaManna, and Patient Advocate, Mel Mann discuss the benefits of modern clinical trials that help pharma sponsors and CROs demonstrate greater collaboration, appreciation, and understanding for the roles of patients and sites.
See why many of the top pharma are focused on building the "next model" of clinical trial conduct using foundational platforms.
Medable's Digital Certification Programs enable you to develop the skills needed to help reshape the drug development paradigm. Click to learn more.
According to Grandview Research, the hybrid and decentralized clinical trial (DCT) market will be worth more than 12 billion dollars by 2030. Sparked by the COVID-19 pandemic of 2020, the rapid ascent of patient-centered technology and the digital and decentralized trials they’ve spawned has forever changed the landscape of clinical conduct. Sponsors are increasingly turning to DCT platforms in alignment with the rise of Life Science and Software-as-a-Service (SaaS) solutions. For those who haven't made the jump yet, there are many questions, including "What is a decentralized clinical trial?" Find out with this in-depth guide to decentralized clinical trials. Uncover how they work, their benefits, and how they transform clinical development.
A panel of industry experts from Sanofi, Bayer, and the Clinical Trials Transformation Initiative (CTTI) recently came together to discuss the evolution of DCTs and share their experiences. You can view that panel here, or read on to see our summarized version of their thoughts.
Accelerate therapeutic discovery and maximize ROI with our streamlined platform, fully integrated across your entire portfolio. Use digital and decentralized trials to scale your pipeline beyond what's possible with traditional clinical trials.
Join a panel of experts and patient advocates discussing effective ways to incorporate patient and caregiver experiences into trial designs. Uncover how Medable drives success by leveraging patient-centric insights and eCOA technology to enhance data quality/compliance, diversity, and retention in clinical trials.
Discover why we must employ every digital solution and innovation available to make the oncology trial experience simpler, easier, and less burdensome for these participants.
Electronic patient-reported outcomes and electronic clinical outcome assessments capture real-time, quality data for clinical trials. Learn how at Medable.
Join leading clinical experts as they discuss and debunk the top 5 myths about eCOA in 2025, separating fact from fiction to help clinical operations, procurement, and data management teams make smarter, faster decisions.
Explore the prevalent challenges encountered in eCOA clinical trials, from technical issues and patient adherence to data security and regulatory adherence, and discover strategies for mitigation.
With MarketsandMarkets projecting the global electronic Clinical Outcome Assessments (eCOA) solutions market to grow at compound annual growth rate (CAGR) of 16.1% each year until 2030, it’s clear the eCOA has made its impact within the clinical research landscape. Yet despite growing adoption, electronic Clinical Outcome Assessments (eCOA) are still surrounded by misconceptions that hinder their full potential. From concerns about patient usability to assumptions about cost and implementation timelines, these myths can create hesitation among sponsors and research teams alike.Thus, we’re here to cut through the noise and set the record straight with a summary of a recent webinar featuring speakers from Transcelerate and Medable.
Medable delivers eConsent and a two-week study startup for a client’s first-ever digital trials
Digital biomarkers, AI, and more are set to transform clinical trials, enhance patient care, and redefine precision medicine.
The landscape of oncology clinical trials is undergoing a significant digital transformation, driven by the imperative for innovation in trial design and execution amidst the increasing volume of cancer research. This shift offers numerous benefits, fundamentally changing how trials are conducted. Digital tools such as eConsent, eCOA/ePRO, and sensor technologies are being integrated into unified platforms, bolstered by real-time data and leading to enhanced efficiency, optimization, and improved data quality.
Alex Burrington, Chief Technology Innovations Principal of Vertex, and Andrew Mckinnon, Vice President and General Manager of E-consent at Medable discuss common myths that continue to persist around eConsent, how to improve comprehension with patient-centric consent, and how to use a digital consent management tool to improve trial compliance, quality, and oversight.
Gain a quick overview of what top trends and topics dominated DIA 2023.
With the 14th annual DPHARM® wrapping up, we talked to our peers across the industry to find out what the big themes and takeaways were from this year’s conference.
Learn how clinical trial data collecting is evolving and how Medable is supporting clients with this blog on evidence generation, clinical trial data, DHTs, sensors, wearables, and more.
Join Medable's Mohammed Ali, Chief Domain Expert and Shubha Govil, SVP of Product Management,Platform to hear how top pharma teams have adopted digital technology across a platform to reduce costs and accelerate time to market.
A top 10 pharmaceutical company looked to Medable to streamline participant burden and enhance site and team experience in oncology trials, while establishing a scalable template for future trials in oncology and other areas.
Learn how standardizing digital strategies and AI can accelerate clinical trials across oncology, vaccines, obesity, and more.
In this webinar, find out how to optimise oncology clinical trials using digital tools to accelerate decision-making.
Consult directly with an award-winning Medable SME about your trial and discover how to enable faster, easier, clinical trials through patient-focused experiences. Chat about best practices in protocol design and digital standardization, learn how the latest FDA & EU guidelines will impact you, or see client use cases on cost and time savings.
Streamline your clinical trial and generate high-quality data with a #1 rated, easy-to-use platform, offered in over 60 countries and 120 languages. Book a demo to learn more.
Joe Dustin, VP/GM of eCOA and Annie Hesslewood, Site & Patient adoption lead at Medable host an open discussion with a panel of sites and CRAs to provide a candid assessment of how upcoming changes in the eCOA landscape can reduce burden on participants and sites to maximize the chance of success in clinical trials.
Learn how top pharma are using novel innovations to drive greater speed, scale, and access in clinical research than ever before in this webinar hosted by Musaddiq Khan, Vice President of DCT Solutions at Medable.
Medable’s Privacy Statement applies to your use of the Medable.com websites (the “Sites”) as well as certain Medable Services (the “Services”).
See how digital and decentralized technologies help remove the barriers that limit diversity within clinical research.
Medable's clinical trial software platform enables faster and easier clinical trials by leveraging digital tools and features like eConsent, eCOA, connected devices, intelligent automation, AI, and more.
In this webinar, learn how top pharma are using novel innovations to drive greater speed, scale, and access in clinical research than ever before in this webinar hosted by Musaddiq Khan, Vice President of DCT Solutions at Medable.
In Medable’s first edition of Evidence and Insights, you’ll discover the culmination of our relentless pursuit of excellence in clinical research technology.